These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24733088)

  • 1. Microfluidic generation of chitosan/CpG oligodeoxynucleotide nanoparticles with enhanced cellular uptake and immunostimulatory properties.
    Chen S; Zhang H; Shi X; Wu H; Hanagata N
    Lab Chip; 2014 Jun; 14(11):1842-9. PubMed ID: 24733088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of novel chitosan-silica/CpG oligodeoxynucleotide nanohybrids with enhanced delivery efficiency.
    Chen S; Zhang H; Chinnathambi S; Hanagata N
    Mater Sci Eng C Mater Biol Appl; 2013 Aug; 33(6):3382-8. PubMed ID: 23706224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunostimulatory properties of CpG-oligonucleotides are enhanced by the use of protamine nanoparticles.
    Kerkmann M; Lochmann D; Weyermann J; Marschner A; Poeck H; Wagner M; Battiany J; Zimmer A; Endres S; Hartmann G
    Oligonucleotides; 2006; 16(4):313-22. PubMed ID: 17155907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A facilely controlled length, cytotoxicity, length-dependent and cell type-dependent cellular uptake of silica nanotubes and their applications in the delivery of immunostimulatory CpG oligodeoxynucleotides.
    Chen S; Zhang Q; Jia L; Du X; Hanagata N
    J Mater Chem B; 2015 Sep; 3(36):7246-7254. PubMed ID: 32262832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intravenous and subcutaneous administration on the pharmacokinetics, biodistribution, cellular uptake and immunostimulatory activity of CpG ODN encapsulated in liposomal nanoparticles.
    Wilson KD; Raney SG; Sekirov L; Chikh G; deJong SD; Cullis PR; Tam YK
    Int Immunopharmacol; 2007 Aug; 7(8):1064-75. PubMed ID: 17570323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-assembling CpG DNA nanoparticles for efficient antigen delivery and immunostimulation.
    Rattanakiat S; Nishikawa M; Takakura Y
    Eur J Pharm Sci; 2012 Sep; 47(2):352-8. PubMed ID: 22771546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytosine-phosphodiester-guanine oligodeoxynucleotide (CpG ODN)-capped hollow mesoporous silica particles for enzyme-triggered drug delivery.
    Zhu Y; Meng W; Hanagata N
    Dalton Trans; 2011 Oct; 40(39):10203-8. PubMed ID: 21901222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunostimulatory activity of CpG oligonucleotides on microglial N9 cells is affected by a polyguanosine motif.
    Zhang Z; Guo K; Schluesener HJ
    J Neuroimmunol; 2005 Apr; 161(1-2):68-77. PubMed ID: 15748945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of CpG oligodeoxynucleotides by human Toll-like receptor 9 and subsequent cytokine induction.
    Suwarti S; Yamazaki T; Svetlana C; Hanagata N
    Biochem Biophys Res Commun; 2013 Jan; 430(4):1234-9. PubMed ID: 23266611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low molecular weight chitosan nanoparticles for CpG oligodeoxynucleotides delivery: Impact of molecular weight, degree of deacetylation, and mannosylation on intracellular uptake and cytokine induction.
    Babii O; Wang Z; Liu G; Martinez EC; van Drunen Littel-van den Hurk S; Chen L
    Int J Biol Macromol; 2020 Sep; 159():46-56. PubMed ID: 32437810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunostimulatory DNA activates production of type I interferons and interleukin-6 in equine peripheral blood mononuclear cells in vitro.
    Wattrang E; Berg M; Magnusson M
    Vet Immunol Immunopathol; 2005 Sep; 107(3-4):265-79. PubMed ID: 15955566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of monodispersed chitosan microspheres and in situ encapsulation of BSA in a co-axial microfluidic device.
    Xu JH; Li SW; Tostado C; Lan WJ; Luo GS
    Biomed Microdevices; 2009 Feb; 11(1):243-9. PubMed ID: 18810642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of circulation lifetime and drug-to-lipid ratio of intravenously administered lipid nanoparticles on the biodistribution and immunostimulatory activity of encapsulated CpG-ODN.
    Raney SG; Wilson KD; Sekirov L; Chikh G; de Jong SD; Cullis PR; Tam YK
    J Drug Target; 2008 Aug; 16(7):564-77. PubMed ID: 18686126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HBV effects of CpG oligodeoxynucleotide-activated peripheral blood mononuclear cells from patients with chronic hepatitis B.
    Li N; Fan XG; Chen ZH; Huang Y; Quan J; Liu ZB
    APMIS; 2005 Oct; 113(10):647-54. PubMed ID: 16309422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant Activity of Poly-ε-caprolactone/Chitosan Nanoparticles Characterized by Mast Cell Activation and IFN-γ and IL-17 Production.
    Jesus S; Soares E; Borchard G; Borges O
    Mol Pharm; 2018 Jan; 15(1):72-82. PubMed ID: 29160080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microfluidic synthesis of chitosan-based nanoparticles for fuel cell applications.
    Majedi FS; Hasani-Sadrabadi MM; Emami SH; Taghipoor M; Dashtimoghadam E; Bertsch A; Moaddel H; Renaud P
    Chem Commun (Camb); 2012 Aug; 48(62):7744-6. PubMed ID: 22760418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan nanoparticles fabricated through host-guest interaction for enhancing the immunostimulatory effect of CpG oligodeoxynucleotide.
    Wang Z; van Drunen Littel-van den Hurk S; Chen L
    Carbohydr Polym; 2021 Nov; 271():118417. PubMed ID: 34364558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic stimulation of antigen presenting cells via TLR by combining CpG ODN and poly(γ-glutamic acid)-based nanoparticles as vaccine adjuvants.
    Shima F; Uto T; Akagi T; Akashi M
    Bioconjug Chem; 2013 Jun; 24(6):926-33. PubMed ID: 23631730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan-coated boron nitride nanospheres enhance delivery of CpG oligodeoxynucleotides and induction of cytokines.
    Zhang H; Chen S; Zhi C; Yamazaki T; Hanagata N
    Int J Nanomedicine; 2013; 8():1783-93. PubMed ID: 23674892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly-guanosine strings improve cellular uptake and stimulatory activity of phosphodiester CpG oligonucleotides in human leukocytes.
    Bartz H; Mendoza Y; Gebker M; Fischborn T; Heeg K; Dalpke A
    Vaccine; 2004 Nov; 23(2):148-55. PubMed ID: 15531031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.